Product Description
Daclatasvir TabletsDaclahep 60mg Tablet is used in combination with other medications such as sofosbuvir, interferon and ribavirin for the treatment of hepatitis C infection.
On using this medication you may experience side effects such as nausea, headache, weakness, fatigue, breakdown of the red cell, diarrhoea, drowsiness, dizziness and skin rash. If your reactions persist or become worse over time seek the help of your health care provider right away.
Advanced Antiviral Therapy for Hepatitis CDaclatasvir Tablets deliver reliable efficacy in the management of chronic hepatitis C virus (HCV) infections. As an NS5A inhibitor, Daclatasvir works by blocking virus multiplication in the body. With high purity and medicine-grade quality, these tablets are suitable for co-administration with Sofosbuvir, enhancing treatment outcomes and increasing sustained virologic response rates in patients.
Convenient Packaging and StorageEach blister pack contains 28 film-coated tablets, ensuring ease of dosage tracking and freshness. The packaging is designed to preserve product integrity during transportation and storage. The tablets should be kept below 30C in a dry location, ensuring efficacy is maintained throughout their 24-month shelf life from the manufacturing date.
Trustworthy Supply and Global ReachOriginating from reputable manufacturers and suppliers in India, Daclatasvir Tablets are readily available for export and wholesale distribution. With a minimum order quantity of just one box, dealers, distributors, and healthcare providers can access this vital medication efficiently, ensuring timely supply for patients worldwide.
FAQs of Daclatasvir Tablets:
Q: How should Daclatasvir Tablets be administered for effective treatment?
A: Daclatasvir Tablets are intended for oral use and should be taken exactly as prescribed by a healthcare professional. Each dose typically consists of one 60 mg tablet daily, and the medication is often used in combination with Sofosbuvir for best results.
Q: What conditions are Daclatasvir Tablets indicated for?
A: These tablets are indicated for the treatment of chronic hepatitis C virus (HCV) infection and are effective in patients with various HCV genotypes, especially when used with other antiviral agents like Sofosbuvir.
Q: When should you begin taking Daclatasvir Tablets?
A: Daclatasvir treatment should be started following a thorough evaluation and diagnosis by a qualified healthcare provider. The timing and duration will depend on the patients specific HCV genotype, liver status, and combination therapy plan.
Q: Where should Daclatasvir Tablets be stored to maintain their efficacy?
A: Daclatasvir Tablets should be stored below 30C in a dry place, away from moisture and direct sunlight. Proper storage protects the medications effectiveness over its 24-month shelf life.
Q: What is the process for obtaining Daclatasvir Tablets?
A: As a prescription-only medication, Daclatasvir Tablets must be obtained through a licensed healthcare provider or pharmacy. Dealers and distributors can source the product from certified suppliers and manufacturers, with a minimum order quantity of one box (28 tablets per box).
Q: What are the potential side effects of Daclatasvir Tablets?
A: The most commonly reported side effects include headache, fatigue, and nausea. It is important to report any unusual or severe reactions to your doctor promptly for proper assessment and care.
Q: What benefits can patients expect from using Daclatasvir Tablets in hepatitis C treatment?
A: When used as directed, especially in combination with Sofosbuvir, Daclatasvir Tablets can substantially improve cure rates, suppress viral replication, and reduce the risk of long-term liver complications associated with chronic HCV infection.